feed,title,long_url,short_url
Investors,The Important — And Overlooked — Caveat Behind Pfizer's Rival To Novo Nordisk In Diabetes,https://www.investors.com/news/technology/pfizer-stock-the-one-caveat-investors-missed-with-its-ozempic-rival/,https://da.gd/y1cNo
